1TNR
CRYSTAL STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX: IMPLICATIONS FOR TNF RECEPTOR ACTIVATION
Experimental procedure
| Spacegroup name | I 2 3 |
| Unit cell lengths | 145.640, 145.640, 145.640 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 50.000 - 2.850 |
| R-factor | 0.16 |
| Rwork | 0.160 |
| RMSD bond length | 0.012 |
| RMSD bond angle | 1.800 |
| Phasing software | X-PLOR |
| Refinement software | X-PLOR |
Data quality characteristics
| Overall | |
| High resolution limit [Å] | 2.830 * |
| Rmerge | 0.078 * |
| Total number of observations | 43171 * |
| Number of reflections | 13270 * |
| Completeness [%] | 99.7 * |
Crystallization Reagents in Literatures
| ID | crystal ID | solution | reagent name | concentration (unit) | details |
| 1 | 1 | reservoir | PEG4000 | 15 (%) | |
| 2 | 1 | reservoir | 200-400 (mM) | ||
| 3 | 1 | reservoir | beta-octyl glucoside | 2 (%) | |
| 4 | 1 | reservoir | sodium cacodylate | 100 (mM) |






